Sign Up to Receive Your Personalised Learning Resources

JOURNALS
Heart International achieves new Impact Factor milestone of 1.9 in 2024 Journal Citation Reports
Start Learning
Expanded treatment choices in obesity care
Sponsored content
Heart International achieves new Impact Factor milestone of 1.9 in 2024 Journal Citation Reports
Ifetroban improves heart function in Duchenne muscular dystrophy: Promising phase II trial results from FIGHT
3 Questions with Dr Salik Ur Rehman Iqbal: touchCARDIO Future Leader 2025
Surgery versus fibrinolytic therapy in SAFE-PVT
Ischaemic left ventricular systolic dysfunction: REVIVED-BCIS2 and STICH trials
Wearable devices show comparable efficacy of digoxin and beta-blockers in managing atrial fibrillation
Long-term hepatic safety of lomitapide in homozygous familial hypercholesterolemia
Sponsored content
The path from detection to personalized long-term care for Fabry disease
CE/CME ACCREDITED
Neuromodulation and Vagal Denervation: Techniques and Implications for Atrial Fibrillation Ablation Outcomes
Expanded treatment choices in obesity care
Sponsored content
Heart International achieves new Impact Factor milestone of 1.9 in 2024 Journal Citation Reports
Ifetroban improves heart function in Duchenne muscular dystrophy: Promising phase II trial results from FIGHT
3 Questions with Dr Salik Ur Rehman Iqbal: touchCARDIO Future Leader 2025
Surgery versus fibrinolytic therapy in SAFE-PVT
Ischaemic left ventricular systolic dysfunction: REVIVED-BCIS2 and STICH trials
Wearable devices show comparable efficacy of digoxin and beta-blockers in managing atrial fibrillation
Long-term hepatic safety of lomitapide in homozygous familial hypercholesterolemia
Sponsored content
The path from detection to personalized long-term care for Fabry disease
CE/CME ACCREDITED
Neuromodulation and Vagal Denervation: Techniques and Implications for Atrial Fibrillation Ablation Outcomes
Expanded treatment choices in obesity care
Sponsored content
Heart International achieves new Impact Factor milestone of 1.9 in 2024 Journal Citation Reports
Ifetroban improves heart function in Duchenne muscular dystrophy: Promising phase II trial results from FIGHT
3 Questions with Dr Salik Ur Rehman Iqbal: touchCARDIO Future Leader 2025
Sign up to view Favourites, Keep Notes and Track CME Credits
Favourites
Are heart health improvements reaching everyone?
View
Expanded treatment choices in obesity care
View
Pulmonary arterial hypertension: A practical roadmap from diagnosis to treatment
View
Long-term hepatic safety of lomitapide in homozygous familial hypercholesterolemia
View
Understanding Diabetic Cardiomyopathy: Insulin Resistance and Beyond
View
The next frontier in managing obesity with or without T2D: The role of novel combinations
View
3 Questions with Dr Salik Ur Rehman Iqbal: touchCARDIO Future Leader 2025
View
Flecainide to prevent atrial arrhythmia in the AFLOAT study
View
Introducing the touchCARDIO Future Leaders 2025
View
Heart Rhythm Congress 2024, 6-8 October 2024, The International Convention Centre, Birmingham, UK
View
Journal articles and more to your inbox
Get the latest clinical insights from touchCARDIO
Sign me up!